{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:40:42Z","timestamp":1792431642062,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-025-01373-x","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T13:33:20Z","timestamp":1745847200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Child with Cutaneous-Skeletal Hypophosphatemia Syndrome Caused by a Mosaic HRAS Mutation: Outcome of Treatment with Anti-FGF23 Antibody"],"prefix":"10.1007","volume":"116","author":[{"given":"Jing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoqian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3053-2756","authenticated-orcid":false,"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"1373_CR1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI159330","volume":"133","author":"D Ovejero","year":"2023","unstructured":"Ovejero D, Michel Z, Cataisson C, Saikali A, Galisteo R, Yuspa SH, Collins MT, de Castro LF (2023) Murine models of HRAS-mediated cutaneous skeletal hypophosphatemia syndrome suggest bone as the FGF23 excess source. J Clin Invest 133:e159330","journal-title":"J Clin Invest"},{"key":"1373_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jaad.2015.11.012","volume":"75","author":"YH Lim","year":"2016","unstructured":"Lim YH, Ovejero D, Derrick KM, Collins MT, Choate KA (2016) Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy. J Am Acad Dermatol 75:420\u2013427","journal-title":"J Am Acad Dermatol"},{"key":"1373_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0022-3476(77)80444-7","volume":"91","author":"LC Aschinberg","year":"1977","unstructured":"Aschinberg LC, Solomon LM, Zeis PM, Justice P, Rosenthal IM (1977) Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions. J Pediatr 91:56\u201360","journal-title":"J Pediatr"},{"key":"1373_CR4","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1007\/s00198-016-3702-8","volume":"27","author":"D Ovejero","year":"2016","unstructured":"Ovejero D, Lim YH, Boyce AM, Gafni RI, McCarthy E, Nguyen TA, Eichenfield LF, DeKlotz CM, Guthrie LC, Tosi LL, Thornton PS, Choate KA, Collins MT (2016) Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment. Osteoporos Int 27:3615\u20133626","journal-title":"Osteoporos Int"},{"key":"1373_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/ddt429","volume":"23","author":"YH Lim","year":"2014","unstructured":"Lim YH, Ovejero D, Sugarman JS, Deklotz CM, Maruri A, Eichenfield LF, Kelley PK, J\u00fcppner H, Gottschalk M, Tifft CJ, Gafni RI, Boyce AM, Cowen EW, Bhattacharyya N, Guthrie LC, Gahl WA, Golas G, Loring EC, Overton JD, Mane SM, Lifton RP, Levy ML, Collins MT, Choate KA (2014) Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia. Hum Mol Genet 23:397\u2013407","journal-title":"Hum Mol Genet"},{"key":"1373_CR6","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1530\/EJE-19-0969","volume":"182","author":"LF de Castro","year":"2020","unstructured":"de Castro LF, Ovejero D, Boyce AM (2020) DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia\/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome. Eur J Endocrinol 182:R83\u2013R99","journal-title":"Eur J Endocrinol"},{"key":"1373_CR7","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, J\u00fcppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656\u20131663","journal-title":"N Engl J Med"},{"key":"1373_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10190","volume":"3","author":"EA Imel","year":"2019","unstructured":"Imel EA, Biggin A, Schindeler A, Munns CF (2019) FGF23, hypophosphatemia, and emerging treatments. JBMR Plus 3:e10190","journal-title":"JBMR Plus"},{"key":"1373_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00223-020-00705-3","volume":"108","author":"D Athonvarangkul","year":"2021","unstructured":"Athonvarangkul D, Insogna KL (2021) New therapies for hypophosphatemia-related to FGF23 excess. Calcif Tissue Int 108:143\u2013157","journal-title":"Calcif Tissue Int"},{"key":"1373_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2023.101725","volume":"20","author":"L Abebe","year":"2024","unstructured":"Abebe L, Phung K, Robinson ME, Waldner R, Carsen S, Smit K, Tice A, Lazier J, Armour C, Page M, Dover S, Rauch F, Koujok K, Ward LM (2024) Burosumab for the treatment of cutaneous-skeletal hypophosphatemia syndrome. Bone Rep 20:101725","journal-title":"Bone Rep"},{"key":"1373_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116598","volume":"166","author":"J Sugarman","year":"2023","unstructured":"Sugarman J, Maruri A, Hamilton DJ, Tabatabai L, Luca D, Cimms T, Krolczyk S, Roberts MS, Carpenter TO (2023) The efficacy and safety of burosumab in two patients with cutaneous skeletal hypophosphatemia syndrome. Bone 166:116598","journal-title":"Bone"},{"key":"1373_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.866831","volume":"13","author":"LM Merz","year":"2022","unstructured":"Merz LM, Buerger F, Ziegelasch N, Zenker M, Wieland I, Lipek T, Wallborn T, Terliesner N, Prenzel F, Siekmeyer M, Dittrich K (2022) A case report: first long-term treatment with burosumab in a patient with cutaneous-skeletal hypophosphatemia syndrome. Front Endocrinol (Lausanne) 13:866831","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1373_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2022.101605","volume":"17","author":"C Huynh","year":"2022","unstructured":"Huynh C, Gillis A, Fazendin J, Abdullatif H (2022) A case report to assess the safety and efficacy of Burosumab, an investigational antibody to FGF23, in a single pediatric patient with Epidermal Nevus Syndrome and associated hypophosphatemic rickets. Bone Rep 17:101605","journal-title":"Bone Rep"},{"key":"1373_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2021.101138","volume":"15","author":"M Khadora","year":"2021","unstructured":"Khadora M, Mughal MZ (2021) Burosumab treatment in a child with cutaneous skeletal hypophosphatemia syndrome: a case report. Bone Rep 15:101138","journal-title":"Bone Rep"},{"issue":"395\u2013399","key":"1373_CR15","first-page":"391","volume":"150","author":"R Geiger","year":"2007","unstructured":"Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fischer V, Geiger H, Loeckinger A, Stein JI (2007) Six-minute walk test in children and adolescents. J Pediatr 150(395\u2013399):391\u2013399","journal-title":"J Pediatr"},{"key":"1373_CR16","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1007\/s10072-020-04600-5","volume":"41","author":"P Pavone","year":"2020","unstructured":"Pavone P, Polizzi A, Marino SD, Corsello G, Falsaperla R, Marino S, Ruggieri M (2020) West syndrome: a comprehensive review. Neurol Sci 41:3547\u20133562","journal-title":"Neurol Sci"},{"key":"1373_CR17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ng.2316","volume":"44","author":"L Groesser","year":"2012","unstructured":"Groesser L, Herschberger E, Ruetten A, Ruivenkamp C, Lopriore E, Zutt M, Langmann T, Singer S, Klingseisen L, Schneider-Brachert W, Toll A, Real FX, Landthaler M, Hafner C (2012) Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat Genet 44:783\u2013787","journal-title":"Nat Genet"},{"key":"1373_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00428-023-03619-1","volume":"483","author":"P Subramanian","year":"2023","unstructured":"Subramanian P, Deshmukh A, Kante K, Patil A, Pai T, Kaur R, Rane S, Shetty O, Ankathi SK, Mittal N (2023) HRAS-mutated primary thyroid malignant melanoma or medullary thyroid carcinoma with melanocytic dedifferentiation? A singular case with an ontogeny-phylogeny quandary. Virchows Arch 483:421\u2013429","journal-title":"Virchows Arch"},{"key":"1373_CR19","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.2034","volume":"102","author":"S Katsuie","year":"2022","unstructured":"Katsuie S, Kiniwa Y, Mikoshiba A, Goto K, Okuyama R (2022) A case of apocrine carcinoma arising in a Sebaceous naevus: detection of HRAS G13R Mutation. Acta Derm Venereol 102:v697","journal-title":"Acta Derm Venereol"},{"key":"1373_CR20","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1111\/1346-8138.15682","volume":"48","author":"A Narahira","year":"2021","unstructured":"Narahira A, Kitamura S, Maeda T, Nishihara H, Yanagi T (2021) Multiple squamous cell carcinomas arising on an epidermal nevus harboring HRAS p. G13R mutation. J Dermatol 48:e92\u2013e93","journal-title":"J Dermatol"},{"key":"1373_CR21","doi-asserted-by":"publisher","first-page":"1928121","DOI":"10.1155\/2020\/1928121","volume":"2020","author":"STM De Los","year":"2020","unstructured":"De Los STM, Del \u00c1C, Lu-de LL, Nu\u00f1ez-Almache O, Ch\u00e1vez-Tejada EM, Espinoza-Robles OA, Pinto-Ib\u00e1rcena PM, Calagua-Quispe MR (2020) Association of central precocious puberty with a rare presentation of Schimmelpenning-Feuerstein-Mims syndrome in a Peruvian girl. Case Rep Endocrinol 2020:1928121","journal-title":"Case Rep Endocrinol"},{"key":"1373_CR22","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/gcc.23092","volume":"61","author":"D Carli","year":"2022","unstructured":"Carli D, Cardaropoli S, Tessaris D, Coppo P, La Selva R, Cesario C, Lepri FR, Pullano V, Palumbo M, Ramenghi U, Brusco A, Medico E, De Sanctis L, Ferrero GB, Mussa A (2022) Successful treatment with MEK-inhibitor in a patient with NRAS-related cutaneous skeletal hypophosphatemia syndrome. Genes Chromosomes Cancer 61:740\u2013746","journal-title":"Genes Chromosomes Cancer"},{"key":"1373_CR23","doi-asserted-by":"publisher","first-page":"E132","DOI":"10.1210\/jc.2013-2813","volume":"99","author":"E Avitan-Hersh","year":"2014","unstructured":"Avitan-Hersh E, Tatur S, Indelman M, Gepstein V, Shreter R, Hershkovitz D, Brick R, Bergman R, Tiosano D (2014) Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23. J Clin Endocrinol Metab 99:E132\u2013E136","journal-title":"J Clin Endocrinol Metab"},{"key":"1373_CR24","first-page":"665","volume":"48","author":"PG Park","year":"2018","unstructured":"Park PG, Park E, Hyun HS, Kang HG, Ha IS, Cho TJ, Ko JM, Cheong HI (2018) Cutaneous skeletal hypophosphatemia syndrome in association with a mosaic HRAS mutation. Ann Clin Lab Sci 48:665\u2013669","journal-title":"Ann Clin Lab Sci"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-025-01373-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:20:30Z","timestamp":1766755230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-025-01373-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1007\/s00223-025-01373-x","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jing Wu, Qiaoyu Cao, Wei Lu, Chengjun Sun, Qiuyue Li, Rong Ye, Ruoqian Cheng, Feihong Luo, and Ming Li declare that there are no potential conflicts of interest regarding the publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committees of Children\u2019s Hospital of Fudan University in Shanghai, China, and informed consents were obtained from this family.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"65"}}